Haque, Md. AminulRiyadh, S. M.2022-04-042022-04-0420212021-12ID 17146009http://hdl.handle.net/10361/16507Cataloged from PDF version of thesis report.Includes bibliographical references (pages 27-33).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.Rheumatoid arthritis (RA) is an autoimmune condition that causes chronic joint inflammation pain, eventually leading to significant bone and cartilage damage in the affected joint. Around the world, RA affects a large number of people in their later years. The most frequent joints affected by RA are the elbow, shoulder and metacarpophalangeal joints. Conventional medication previously only treated the symptoms of RA. To treat the etiology of RA, biological disease modifying anti-rheumatic medicines (bDMARDs) target biological receptors such as TNF-alpha, IL-1 and IL-6. This review article discusses the benefits of using biological disease modifiers.33 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Rheumatoid arthritisTNF-alphaInterleukinDisease-modifying anti rheumatic drugsBiological disease-modifying anti rheumatic drugsRheumatoid arthritis -- Pathogenesis.Thesis